← Back to Clinical Trials
Recruiting NCT06703151

NCT06703151 To Understand the Self-care Ability of Farmers and Fishermen With CMDs (Hypertension, Heart Disease, Hyperlipidemia, Type 2 Diabetes), Whether They Are Aware of CMDs, Their Treatment Status, Treatment Effectiveness, and Their Ability to Describe Known and Practice the Self-care Content of CMDs.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06703151
Status Recruiting
Phase
Sponsor Chang Gung Memorial Hospital
Condition Cardiovascular Disease
Study Type INTERVENTIONAL
Enrollment 338 participants
Start Date 2024-12-02
Primary Completion 2025-02-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
CMDs (Cardiometabolic Diseases) Self-Care Manual

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 338 participants in total. It began in 2024-12-02 with a primary completion date of 2025-02-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project will be based on nursing scholar Dorothea Orem's self-care theory, integrating the concept of the \[life essential 8, LE8\] proposed by the American Heart Association, as well as our team's recent research findings. We aim to develop educational materials and tools tailored for this group, termed \[Self-Care Eight Essentials\] aligning with these theories and previous research outcomes. This study aims to present an overview of self-care abilities among farmers and fishermen with cardiovascular and metabolic diseases, identifying the distance from the ideal level and related influencing factors. It intends to establish self-care educational materials and tools tailored to the socioeconomic background of this specific population. Additionally, the study aims to transform these materials into tabletop game educational tools that possess credibility, effectiveness, and an element of entertainment. Through patents and technology transfer, these tools are expected to serve as convenient and effective guidance instruments for health bureaus and primary healthcare units.

Eligibility Criteria

Inclusion Criteria: * Farmers and fishermen who have been diagnosed with CMDs * Aged between 18 and 75 years old * Able to take care of their own daily life and can walk to the unit or community activity center that cooperates with this project * Can communicate with Taiwanese and Mandarin, and agree to participate in the second and third years of this study Exclusion Criteria: * Those who have no household registration or live in an unstable place in the study area * Those who have had a stroke or myocardial infarction * Those who have kidney and heart failure diseases and have limited water intake * Those who have cognitive or mental disorders

Contact & Investigator

Central Contact

Mei-Yen Chen, Distinguished Professor

✉ meiyen@mail.cgust.edu.tw

📞 886-5-3628800

Principal Investigator

Mei-Yen Chen, Distinguished Professor

PRINCIPAL INVESTIGATOR

Chang Gung University of Science and Technology

Frequently Asked Questions

Who can join the NCT06703151 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Cardiovascular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06703151 currently recruiting?

Yes, NCT06703151 is actively recruiting participants. Contact the research team at meiyen@mail.cgust.edu.tw for enrollment information.

Where is the NCT06703151 trial being conducted?

This trial is being conducted at Mailiao, Taiwan.

Who is sponsoring the NCT06703151 clinical trial?

NCT06703151 is sponsored by Chang Gung Memorial Hospital. The principal investigator is Mei-Yen Chen, Distinguished Professor at Chang Gung University of Science and Technology. The trial plans to enroll 338 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology